Hostname: page-component-76fb5796d-vfjqv Total loading time: 0 Render date: 2024-04-26T13:21:38.122Z Has data issue: false hasContentIssue false
  • English
  • Français

A Cluster of Vancomycin-Resistant Enterococcus faecium in an Intensive Care Unit

Published online by Cambridge University Press:  21 June 2016

Lynne V. Karanfil ,
Mary Murphy ,
Adele Josephson ,
Robert Gaynes ,
Laura Mandel ,
Bertha C. Hill  and
Jana M. Swenson
Lynne V. Karanfil*
Affiliation:
Epidemiology Department, University Hospital
Mary Murphy
Affiliation:
Infectious Disease Division, Department of Medicine
Adele Josephson
Affiliation:
Epidemiology Department, University Hospital
Robert Gaynes
Affiliation:
SUNY-Health Science Center at Brooklyn, and the, Hospital Infections Program, Centers for Disease Control
Laura Mandel
Affiliation:
Infectious Disease Division, Department of Medicine
Bertha C. Hill
Affiliation:
SUNY-Health Science Center at Brooklyn, and the, Hospital Infections Program, Centers for Disease Control
Jana M. Swenson
Affiliation:
SUNY-Health Science Center at Brooklyn, and the, Hospital Infections Program, Centers for Disease Control
*
The Johns Hopkins Hospital, Department of Infection Control, 600 North Wolfe Street/ParkB112, Baltimore, MD 21205
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

To describe the epidemiology of a cluster of vancomycin-resistant Enterococcus faecium (VAREC) in a cardiothoracic surgery intensive care unit.

Design:

A case series of patients identified through review of surveillance data on nosocomial infections, review of microbiologic records, and culture survey of patients in the unit.

Results:

Six patients in the cardiothoracic surgery intensive care unit had VAREC with identical antimicrobic susceptibility patterns over a 6-month period. Four patients were identified with VAREC through prospective surveillance and 2 through retrospective review. Prior vancomycin use was seen more commonly in patients with VAREC (6/6,100%) than in those without VAREC (3/12, 25%) (Fisher’s exact test, p= .01). Six of the 7 patients with prior infection developed VAREC (85.7%). A prior nosocomial infection and prior exposure to vancomycin were found to be important variables in a logistic regression analysis. VAREC also was isolated from the environment. Acombination of cohorting of patients and staff, and modifications of standard contact isolation practices eliminated the presence of VAREC from the cardiothoracic surgery intensive care unit.

Conclusions:

The results suggest that prior administration of vancomycin, especially in the patient who develops nosocomial infection, can influence the acquisition of vancomycin-resistant enterococci and that VAREC may be transmitted from patient to patient. Using a modification of the standard infection control practice of isolation, we were able to control the spread of this resistant strain of E faecium.

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 13 , Issue 4 , April 1992 , pp. 195 - 200
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1992

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Lewis, CM, Zervos, MJ. Clinical manifestations of enterococcal infection. Eur J Clin Microbiol Infect Dis. 1990;9:111–117.Google Scholar
2. Schaberg, DR, Culver, DC, Gaynes, RF! Major trends in the microbialetiology of nosocomial infection. Am J Med. 1991;3B:72S–75s. Google Scholar
3. Zervos, MJ, Kauffman, CA, Therasse, PM, Bergman, AG, Mikesell, TS, Schaberg, DR. Nosocomial infection by gentamicin-resistant Streptococcus faecalis: an epidemiologic study. Ann Intern Med. 1987;106:687–691.Google Scholar
4. Rhinehart, E, Smith, N, Wennersten, C, et al. Rapid dissemination of β-lactamase-producing aminoglycosideresistant Enterococcus faecalis among patients and staff on an infant-toddler surgical ward. N Engl J Med. 1990;323:1814–1818.Google Scholar
5. Leclercq, R, Derlot, E, Duval, J, Courvalin, R. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium . N Engl J Med. 1988;319:157–161.Google Scholar
6. Leclercq, R, Derlot, E, Weber, M, Duval, J, Courvalin, R. Transferable vancomycin and teicoplanin resistance in Enterococcus faecium . Antimicrob Agents Chemother. 1989; 33:10–15 Google Scholar
7. Emori, TG, Culver, DH, Horan, TC, et al. National Nosocomial Infections Surveillance (NNIS) System: description of surveillance methodology. Am J Infect Control. 1991;19:19–35.Google Scholar
8. Garner, JS, Jarvis, WR, Emori, TG, Horan, TC, Hughes, JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control. 1988;16:128–140.Google Scholar
9. Garner, JS, Simmons, BP. CDC. Guidelines for Isolation Precautions in Hospitals. Atlanta, Ga: Centers for Disease Control; 1983.Google Scholar
10. Lennette, EH, Balows, A, Hausler, WJ, Shadomy, HJ, eds. Manual of Clinical Microbiology. Washington, DC: American Society for Microbiology: 1985.Google Scholar
11. National Committee for Clinical Laboratory Standards, Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically. M7-T2. Villanova, Penn: National Committee for Clinical Laboratory Standards; 1988.Google Scholar
12. Kleinbaum, DG, Kupper, LL, Morganstern, H. Epidemiologic Research, Principles and Quantitative Methods. New York, NY: Van Nostrand Reingold Co; 1982.Google Scholar
13. SPSS Users Guide, Version 4.1. Chicago, Ill: SPSS, Inc.; 1990.Google Scholar
14. Livornese, LL, Johnson, CC, Dias, S, et al. Hospital-acquired infection with vancomycin-resistant Enterococcus faecium. Presented at the 31st Interscience Conference on Antimicrobial Agents and Chemotherapy. September 29 October 3. 1991. Chicago, Ill. Abstract 398.Google Scholar
15. Utley, AHC. Collins, CH, Naidoo, J, George, RD. Vancomycin-resistant enterococci. Lancet. 1988;i:57—58.Google Scholar
16. Kaplan, AH, Gilligan, PH, Facklam, RR. Recovery of resistant enterococci during vancomycin prophylaxis. J Clin Microbiol. 1988;26:1216–1218.Google Scholar
17. Rubin, LG, Tucci, V, Weber, JM, Isenberg, HD. Vancomycin-resistant Enterococcus faecium in hospitalized children. Presented at the 31st Interscience Conference on Antimicrobial Agents and Chemotherapy. September 29-October 3, 1991. Chicago, Ill. Abstract 395.Google Scholar
18. Weinstein, RA. Epidemiology and control of nosocomial infections in adult intensive care units. Am J Med. 1991;3b:179S—184S.Google Scholar
19. MRSA controls include feedback, glove changes by task. Hosp Infect control. 1990;17:130–131.Google Scholar
20. Lynch, P, Jackson, MM, Cummings, MJ, Stamm, WE. Rethinking the role of isolation practices in the prevention of nosocomial infections. Ann Intern Med. 1987;3b:243—246.Google Scholar
21. Tenover, E. Novel and emerging mechanisms of antimicrobial resistance in nosocomial pathogens. Am J Med. 1991;3b:76s—81s.Google Scholar